Manulife (Manufacturers Life Insurance)’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-875
Closed -$31.8K 3085
2023
Q1
$31.8K Hold
875
﹤0.01% 2897
2022
Q4
$52.8K Buy
875
+67
+8% +$4.49K ﹤0.01% 2910
2022
Q3
$60.6K Sell
808
-35
-4% -$3.66K ﹤0.01% 2902
2022
Q2
$96.6K Buy
843
+190
+29% +$22.3K ﹤0.01% 2916
2022
Q1
$124K Buy
+653
New +$151K ﹤0.01% 2920

Other funds holding OMIC

Manulife (Manufacturers Life Insurance)'s OMIC Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 875 shares — an estimated $31.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in OMIC in Q1 2022 and held it in 5 quarters. The position peaked at $124K in Q1 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 875 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $31.8K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Singular Genomics Systems, Inc. Common Stock position peaked at $124K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.